Annual Total Long Term Liabilities
$230.56 M
-$312.27 M-57.53%
December 31, 2022
Summary
- As of February 10, 2025, ICPT annual total long term liabilities is $230.56 million, with the most recent change of -$312.27 million (-57.53%) on December 31, 2022.
- During the last 3 years, ICPT annual total long term liabilities has fallen by -$310.77 million (-57.41%).
Performance
ICPT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$230.47 M
+$405.00 K+0.18%
September 30, 2023
Summary
- As of February 10, 2025, ICPT quarterly total long term liabilities is $230.47 million, with the most recent change of +$405.00 thousand (+0.18%) on September 30, 2023.
- Over the past year, ICPT quarterly long term liabilities has increased by +$328.00 thousand (+0.14%).
Performance
ICPT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ICPT Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.5% | +0.1% |
| 3 y3 years | -57.4% | -58.7% |
| 5 y5 years | -36.6% | -38.2% |
ICPT Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.5% | at low | -68.2% | -0.3% |
| 5 y | 5-year | -59.4% | at low | -68.2% | -0.3% |
| alltime | all time | -59.4% | -97.3% | -68.2% | -97.7% |
Intercept Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $230.47 M(+0.2%) |
| Jun 2023 | - | $230.07 M(+0.1%) |
| Mar 2023 | - | $229.78 M(-0.3%) |
| Dec 2022 | $230.56 M(-57.5%) | $230.56 M(+0.2%) |
| Sep 2022 | - | $230.14 M(-67.9%) |
| Jun 2022 | - | $717.00 M(-1.0%) |
| Mar 2022 | - | $724.08 M(+33.4%) |
| Dec 2021 | $542.82 M(-4.5%) | $542.82 M(+1.4%) |
| Sep 2021 | - | $535.25 M(-7.9%) |
| Jun 2021 | - | $581.14 M(+1.3%) |
| Mar 2021 | - | $573.88 M(+1.0%) |
| Dec 2020 | $568.27 M(+5.0%) | $568.27 M(+1.7%) |
| Sep 2020 | - | $558.51 M(+1.0%) |
| Jun 2020 | - | $552.75 M(+1.0%) |
| Mar 2020 | - | $547.13 M(+1.1%) |
| Dec 2019 | $541.33 M(+44.0%) | $541.33 M(+1.9%) |
| Sep 2019 | - | $531.38 M(-3.8%) |
| Jun 2019 | - | $552.53 M(+43.5%) |
| Mar 2019 | - | $384.92 M(+2.4%) |
| Dec 2018 | $375.83 M(+3.3%) | $375.83 M(+0.8%) |
| Sep 2018 | - | $372.73 M(+0.8%) |
| Jun 2018 | - | $369.63 M(+0.8%) |
| Mar 2018 | - | $366.65 M(+0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $363.93 M(+5.2%) | $363.93 M(+0.8%) |
| Sep 2017 | - | $361.17 M(+0.8%) |
| Jun 2017 | - | $358.47 M(+0.9%) |
| Mar 2017 | - | $355.10 M(+2.7%) |
| Dec 2016 | $345.81 M(+5445.4%) | $345.81 M(+0.9%) |
| Sep 2016 | - | $342.80 M(+6313.4%) |
| Jun 2016 | - | $5.34 M(-7.7%) |
| Mar 2016 | - | $5.79 M(-7.2%) |
| Dec 2015 | $6.24 M(-22.2%) | $6.24 M(-6.7%) |
| Sep 2015 | - | $6.68 M(-6.2%) |
| Jun 2015 | - | $7.13 M(-5.9%) |
| Mar 2015 | - | $7.57 M(-5.6%) |
| Dec 2014 | $8.02 M(-86.4%) | $8.02 M(-5.3%) |
| Sep 2014 | - | $8.46 M(-5.0%) |
| Jun 2014 | - | $8.91 M(+4.6%) |
| Mar 2014 | - | $8.51 M(-85.6%) |
| Dec 2013 | $59.03 M(+77.3%) | $59.03 M(-2.3%) |
| Sep 2013 | - | $60.42 M(+49.4%) |
| Jun 2013 | - | $40.43 M(+13.1%) |
| Mar 2013 | - | $35.76 M(+7.4%) |
| Dec 2012 | $33.30 M(+85.0%) | $33.30 M(+97.2%) |
| Sep 2012 | - | $16.89 M(+3.3%) |
| Jun 2012 | - | $16.34 M(-9.2%) |
| Dec 2011 | $18.00 M | $18.00 M |
FAQ
- What is Intercept Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Intercept Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Intercept Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of ICPT is $230.56 M
What is the all time high annual total long term liabilities for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high annual total long term liabilities is $568.27 M
What is Intercept Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, ICPT annual total long term liabilities has changed by -$312.27 M (-57.53%)
What is Intercept Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of ICPT is $230.47 M
What is the all time high quarterly long term liabilities for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high quarterly total long term liabilities is $724.08 M
What is Intercept Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, ICPT quarterly total long term liabilities has changed by +$328.00 K (+0.14%)